Skip to main content

Table 1 Clinical and socio-demographic characteristics of the sample by osteoporosis and morphometric vertebral fracture (%)

From: Impact of osteoporosis and vertebral fractures on quality-of-life. a population-based study in Valencia, Spain (The FRAVO Study)

 

Without vertebral fracture

With Vertebral fracture

Total

 

T-Score

> -2.5

T-Score

≤ -2.5

Mild

Moderate-severe

 

Age group (p < 0.001)

- 50-54 years

86 (79.6)

17 (15.7)

3 (2.8)

2 (1.8)

108 (13.4)

- 55-59 years

118 (77.6)

23 (15.1)

7 (4.6)

4 (2.6)

152 (18.9)

- 60-64 years

117 (69.2)

32 (18.9)

17 (10.1)

3 (1.8)

169 (21.0)

- 65-69 years

99 (59.6)

43 (25.9)

14 (8.4)

10 (6.0)

166 (20.6)

- 70-74 years

68 (47.6)

40 (28.0)

20 (14.0)

15 (10.5)

143 (17.8)

- 75 years and older

22 (33.3)

13 (19.7)

15 (22.7)

16 (24.2)

66 (8.2)

Educational level (p < 0.001)

- Without studies

79 (52.3)

26 (17.2)

25 (16.6)

21 (13.9)

151 (18.8)

- Primary

215 (62.5)

82 (23.8)

28 (8.1)

19 (5.5)

344 (42.8)

- Second./university

132 (69.1)

44 (23.0)

11 (5.8)

4 (2.1)

191 (23.8)

- Unknown

84 (71.2)

16 (13.6)

12 (10.2)

6 (5.1)

118 (14.6)

Densitometry (p < 0.001)

- Normal

146 (90.1)

0 (0.0)

12 (7.4)

4 (2.5)

162 (20.1)

- Osteopenia

364 (87.3)

0 (0.0)

32 (7.7)

21 (5.0)

417 (51.9)

- Osteoporosis

0 (0.0)

168 (74.7)

32 (14.2)

25 (11.1)

225 (28.0)

Chronic conditions (p = 0.094)*

- None

150 (68.8)

49 (22.5)

11 (5.0)

8 (3.7)

218 (27.1)

- 1

176 (61.8)

62 (21.7)

30 (10.5)

17 (6.0)

285 (35.5)

- 2

118 (63.4)

33 (17.7)

19 (10.2)

16 (8.6)

186 (23.1)

- 3 or more

66 (57.4)

24 (20.9)

16 (13.9)

9 (7.8)

115 (14.3)

Antecedents of non-vertebral fracture (p = 0.020)

- No

493 (64.6)

156 (20.4)

69 (9.0)

45 (5.9)

763 (94.9)

- Yes

17 (41.5)

12 (29.3)

7 (17.1)

5 (12.2)

41 (5.1)

Hypoestrogenism antecedents (p = 0.407)

- No

416 (64.0)

131 (20.1)

65 (10.0)

38 (5.8)

650 (80.8)

- Yes

94 (61.0)

37 (24.0)

11 (7.1)

12 (7.8)

154 (19.1)

Obesity BMI>35 (p = 0.010)

- No

447 (62.0)

162 (22.5)

69 (9.6)

43 (6.0)

721 (89.7)

- Yes

63 (75.9)

6 (7.2)

7 (8.4)

7 (8.4)

83 (10.3)

Antiosteoporotic treatment (p < 0.001)

- No

416 (66.4)

119 (19.0)

62 (9.9)

29 (4.6)

626 (77.9)

- Yes

94 (52.8)

49 (27.5)

14 (7.9)

21 (11.8)

178 (22.1)

Vertebral fracture localization (p < 0.001)

- Thoracic

-

-

65 (71.4)

26 (28 .6)

91 (72.2)

- Lumbar

-

-

8 (61.5)

5 (38.5)

13 (10.3)

- Both

-

-

3 (13.6)

19(86.4)

22 (17.5)

TOTAL

510 (63.4)

168 (20.9)

76 (9.4)

50 (6.2)

804 (100)

  1. All percentages by rows except in the total column (by columns). BMI: Body Mass Index. *Chronic conditions: corticoid treatment, gait abnormalities for any reason, cognitive or visual deficit, depression, gastrectomy, bowel resection, inflammatory bowel disease, thyroidectomy, diabetes mellitus, chronic liver diseases, chronic obstructive pulmonary disease, rheumatoid arthritis, chronic kidney failure and transplantation. p-values correspond to Pearson's chi-squared test.